Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry

PURPOSE: Adjuvant endocrine therapy (ET) is indicated in patients with steroid hormone receptor (HR)-positive breast cancer. The aim of this study was to evaluate the quality of HR determination and adjuvant endocrine treatment of breast cancer patients in a large cohort of more than 7000 women by a...

Descripción completa

Detalles Bibliográficos
Autores principales: Inwald, E. C., Koller, M., Klinkhammer-Schalke, M., Zeman, F., Hofstädter, F., Lindberg, P., Gerstenhauer, M., Schüler, S., Treeck, O., Ortmann, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630246/
https://www.ncbi.nlm.nih.gov/pubmed/26253629
http://dx.doi.org/10.1007/s00432-015-2025-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630246/
https://www.ncbi.nlm.nih.gov/pubmed/26253629
http://dx.doi.org/10.1007/s00432-015-2025-z

Ejemplares similares